Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Osimertinib (TAGRISSO) (ROSY-T)
Clinical trial NCT05629234 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05629234
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-08
- Primary completion
- 2027-02-22
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.